文献速递关节外科

关节腔内氨甲环酸减轻全膝关节置换术后失血与吗啡用量:一项随机对照试验

Intra-Articular Tranexamic Acid Mitigates Blood Loss and Morphine Use After Total Knee Arthroplasty. A Randomized Controlled Trial.
PubMed 文献 · J Arthroplasty · 2019-01-23

228例初次全膝关节置换术随机分为无氨甲环酸组、关节腔内氨甲环酸组(15 mg/kg)和静脉氨甲环酸组(10 mg/kg)。关节腔内与静脉氨甲环酸均显著减少围手术期失血量和输血量,关节腔内氨甲环酸还显著降低术后6、12、24小时疼痛评分及48小时吗啡总用量,静脉途径对疼痛无影响。

要点

  • 关节腔内与静脉氨甲环酸均显著减少全膝关节置换围手术期失血量与输血量。
  • 关节腔内氨甲环酸显著降低术后6、12、24小时VAS评分及48小时吗啡用量。
  • 静脉氨甲环酸对疼痛评分及48小时吗啡用量无显著影响。

核心结论

  • 关节腔内与静脉氨甲环酸均可显著减少围手术期失血量和平均输血单位数。
  • 关节腔内氨甲环酸可显著减轻全膝关节置换术后疼痛评分和吗啡用量。
  • 作者认为关节腔内氨甲环酸可减少失血,并可作为全膝关节置换术后疼痛控制的辅助手段考虑。

研究设计与样本

  • 随机对照试验,纳入228例初次全膝关节置换术,随机分为无氨甲环酸组、关节腔内氨甲环酸组(15 mg/kg)和静脉氨甲环酸组(10 mg/kg)。
  • 采用多变量回归分析比较围手术期失血量、引流量、平均输血单位数、疼痛视觉模拟量表评分、吗啡用量和膝关节屈曲角度。

主要发现

  • 关节腔内氨甲环酸组围手术期失血量较无氨甲环酸组少193.26 mL(P < .01),静脉氨甲环酸组较无氨甲环酸组少160.30 mL(P < .01)。
  • 无氨甲环酸组平均输血单位数显著高于关节腔内氨甲环酸组和静脉氨甲环酸组(P = .03)。
  • 关节腔内氨甲环酸组术后6小时(P = .04)、12小时(P = .03)、24小时(P = .02)VAS评分低于无氨甲环酸组,静脉氨甲环酸组无此效果。
  • 关节腔内氨甲环酸组48小时吗啡总用量较无氨甲环酸组少18.26 mg(P = .02),静脉氨甲环酸组较无氨甲环酸组少5.31 mg但未达统计学显著(P = .31)。
  • 两种氨甲环酸途径均倾向于改善膝关节屈曲,但未达统计学显著。

关键数值与推荐

  • 关节腔内氨甲环酸剂量为15 mg/kg,静脉氨甲环酸剂量为10 mg/kg。
  • 关节腔内氨甲环酸组围手术期失血量较无氨甲环酸组少193.26 mL(P < .01),静脉氨甲环酸组少160.30 mL(P < .01)。
  • 关节腔内氨甲环酸组48小时吗啡总用量较无氨甲环酸组少18.26 mg(P = .02),静脉氨甲环酸组少5.31 mg(P = .31)。

临床怎么用

  • 作者认为关节腔内氨甲环酸可减少失血,并可作为全膝关节置换术后疼痛控制的辅助手段考虑。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tranexamic acid (TXA) has been widely used in total knee arthroplasty (TKA) for blood loss reduction. Given limited evidence on potential relationship between the TXA and improvement of pain control and functional outcome after TKA, this study aimed at comparing the blood loss, pain scores, morphine consumption, and knee flexion across the TXA administration routes. METHODS: The 228 primary TKA were randomized into no TXA use (No-TXA), intra-articular TXA (15 mg/kg) use (IA-TXA), and intravenous TXA (10 mg/kg) use (IV-TXA). A multivariate regression analysis was used for comparing perioperative blood loss (PBL), drain output, average number of units of blood transfused (ANUBT), visual analogue scales (VAS) for pain, amount of morphine consumption, and knee flexion angle. RESULTS: The IA-TXA and IV-TXA group had 193.26 (P < .01) and 160.30 mL (P < .01) less PBL than No-TXA, respectively. No-TXA significantly required higher ANUBT than IA-TXA and IV-TXA (P = .03). The IA-TXA group had lower VAS at 6 (P = .04), 12 (P = .03), and 24 hours (P = .02) postoperative when compared to No-TXA, while IV-TXA had no effect. The IA-TXA required 18.26 mg less total morphine at 48 hours than No-TXA (P = .02), whereas IV-TXA used insignificantly (5.31 mg; P = .31) less total morphine at 48 hours than No-TXA. Both TXA routes tended to improve knee flexion, but not statistically significant. CONCLUSION: Both IA-TXA and IV-TXA could significantly reduce PBL and ANUBT. The IA-TXA could significantly mitigate VAS and morphine use after TKA. Hence, IA-TXA could minimize blood loss and may be considered as an adjunct to pain control following TKA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Laoruengthana A, Rattanaprichavej P, Rasamimongkol S, et al. Intra-Articular Tranexamic Acid Mitigates Blood Loss and Morphine Use After Total Knee Arthroplasty. A Randomized Controlled Trial. J Arthroplasty. 2019. PMID: 30755381. doi:10.1016/j.arth.2019.01.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。